These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
430 related articles for article (PubMed ID: 34030630)
1. Burden of migraine and unmet needs from the patients' perspective: a survey across 11 specialized headache clinics in Korea. Kim BK; Chu MK; Yu SJ; Dell'Agnello G; Han JH; Cho SJ J Headache Pain; 2021 May; 22(1):45. PubMed ID: 34030630 [TBL] [Abstract][Full Text] [Related]
2. Validity and reliability of the Greek Migraine-Specific Quality of Life Questionnaire (MSQ Version 2.1-GR). Giannouli E; Giannouli E; Alexoudi A; Arvaniti C; Fakas N; Constantinidis TS; Kouremenos E; Mitsikostas DD; J Patient Rep Outcomes; 2024 Jul; 8(1):72. PubMed ID: 39007966 [TBL] [Abstract][Full Text] [Related]
3. Need for care and perceptions of MIDAS among headache sufferers study. Stewart W; Lipton R CNS Drugs; 2002; 16 Suppl 1():5-11. PubMed ID: 12196034 [TBL] [Abstract][Full Text] [Related]
4. Prevalence, burden, and clinical management of migraine in China, Japan, and South Korea: a comprehensive review of the literature. Takeshima T; Wan Q; Zhang Y; Komori M; Stretton S; Rajan N; Treuer T; Ueda K J Headache Pain; 2019 Dec; 20(1):111. PubMed ID: 31805851 [TBL] [Abstract][Full Text] [Related]
5. A Real-World Analysis of Migraine: A Cross-Sectional Study of Disease Burden and Treatment Patterns. Ford JH; Jackson J; Milligan G; Cotton S; Ahl J; Aurora SK Headache; 2017 Nov; 57(10):1532-1544. PubMed ID: 28984356 [TBL] [Abstract][Full Text] [Related]
6. Migraine-Related Stigma and Its Relationship to Disability, Interictal Burden, and Quality of Life: Results of the OVERCOME (US) Study. Shapiro RE; Nicholson RA; Seng EK; Buse DC; Reed ML; Zagar AJ; Ashina S; Muenzel EJ; Hutchinson S; Pearlman EM; Lipton RB Neurology; 2024 Feb; 102(3):e208074. PubMed ID: 38232340 [TBL] [Abstract][Full Text] [Related]
7. Headache/migraine-related stigma, quality of life, disability, and most bothersome symptom in adults with current versus previous high-frequency headache/migraine and medication overuse: results of the Migraine Report Card survey. Buse DC; Cady R; Starling AJ; Buzby M; Spinale C; Steinberg K; Lenaburg K; Kymes S BMC Neurol; 2024 Jul; 24(1):232. PubMed ID: 38965567 [TBL] [Abstract][Full Text] [Related]
8. Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences. Lipton RB; Munjal S; Alam A; Buse DC; Fanning KM; Reed ML; Schwedt TJ; Dodick DW Headache; 2018 Oct; 58(9):1408-1426. PubMed ID: 30341895 [TBL] [Abstract][Full Text] [Related]
9. A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache-Related Disability. Lipton RB; Manack Adams A; Buse DC; Fanning KM; Reed ML Headache; 2016 Sep; 56(8):1280-9. PubMed ID: 27349336 [TBL] [Abstract][Full Text] [Related]
10. Psychometric Validation of the Role Function Restrictive Domain of the Migraine Specific Quality-of-Life Questionnaire Version 2.1 Electronic Patient-Reported Outcome in Patients With Episodic and Chronic Migraine. Speck RM; Shalhoub H; Wyrwich KW; Yu R; Ayer DW; Ford J; Bush EN; Lipton RB Headache; 2019 May; 59(5):756-774. PubMed ID: 30861580 [TBL] [Abstract][Full Text] [Related]
11. Barriers to the diagnosis and treatment of migraine: effects of sex, income, and headache features. Lipton RB; Serrano D; Holland S; Fanning KM; Reed ML; Buse DC Headache; 2013 Jan; 53(1):81-92. PubMed ID: 23078241 [TBL] [Abstract][Full Text] [Related]
12. Global trends in migraine care: results from the MAZE survey. Brandes JL CNS Drugs; 2002; 16 Suppl 1():13-8. PubMed ID: 12196035 [TBL] [Abstract][Full Text] [Related]
13. Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study. Lipton RB; Hutchinson S; Ailani J; Reed ML; Fanning KM; Manack Adams A; Buse DC Headache; 2019 Nov; 59(10):1762-1772. PubMed ID: 31544244 [TBL] [Abstract][Full Text] [Related]
14. Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine. Silberstein SD; Lee L; Gandhi K; Fitzgerald T; Bell J; Cohen JM Headache; 2018 Nov; 58(10):1579-1592. PubMed ID: 30375650 [TBL] [Abstract][Full Text] [Related]
15. A 3-month analysis of disability, quality of life, and disease course in patients with migraine. Raggi A; Leonardi M; Bussone G; D'Amico D Headache; 2013 Feb; 53(2):297-309. PubMed ID: 23094760 [TBL] [Abstract][Full Text] [Related]
17. Migraine prevalence and treatment patterns: the global Migraine and Zolmitriptan Evaluation survey. MacGregor EA; Brandes J; Eikermann A Headache; 2003 Jan; 43(1):19-26. PubMed ID: 12864754 [TBL] [Abstract][Full Text] [Related]
18. MIDAS and HIT-6 French translation: reliability and correlation between tests. Magnoux E; Freeman MA; Zlotnik G Cephalalgia; 2008 Jan; 28(1):26-34. PubMed ID: 17970768 [TBL] [Abstract][Full Text] [Related]
19. Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study. Buse DC; Serrano D; Reed ML; Kori SH; Cunanan CM; Adams AM; Lipton RB Headache; 2015 Jun; 55(6):825-39. PubMed ID: 25881857 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive population-based survey of migraine in Japan: results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) study. Hirata K; Ueda K; Komori M; Zagar AJ; Selzler KJ; Nelson AM; Han Y; Jaffe DH; Matsumori Y; Takeshima T Curr Med Res Opin; 2021 Nov; 37(11):1945-1955. PubMed ID: 34429000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]